GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

The launch of GLP-1 weight-loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Cramer explained that buying when prices are low helps reduce the risk of starting off with a bad cost basis, which is a ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

ClearBridge Investments, an investment management company, released its “ClearBridge Value Strategy” second quarter 2025 ...

Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...